TTC15 inhibitors represent a class of chemical compounds designed to target and inhibit the TTC15 protein, which is part of the tetratricopeptide repeat (TPR) domain-containing protein family. TTC15 is involved in several cellular processes, particularly in regulating protein-protein interactions and supporting the formation of multi-protein complexes. The TPR domain, which characterizes TTC15, is a structural motif that facilitates binding to other proteins, making TTC15 an important mediator in cellular signaling and protein complex assembly. Inhibitors of TTC15 are developed to disrupt these interactions, either by blocking the binding interface of the TPR domain or by inducing conformational changes in TTC15 that impair its ability to interact with other proteins.
Structurally, TTC15 inhibitors are often small molecules with specific chemical features that allow for high-affinity binding to the TPR domain of TTC15. These compounds are designed to precisely fit into the binding pocket or other active regions of TTC15, effectively interfering with its function while maintaining selectivity to avoid interactions with other TPR-containing proteins. This selectivity is critical for studying TTC15's role in cellular biology, as it allows for the modulation of pathways where TTC15 plays a central role without widespread off-target effects. Researchers studying TTC15 inhibitors focus on understanding how these molecules influence the structural dynamics of the protein, exploring how the inhibition of TTC15 affects broader protein networks and cellular pathways. The detailed study of these inhibitors sheds light on the molecular mechanisms of protein assembly and regulation, with TTC15 being a key player in these processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, which can decrease overall protein levels including TTC15. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport by inhibiting the exchange of protein and other substances between cellular organelles, which can affect TTC15 if it relies on intracellular trafficking. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that blocks the degradation of ubiquitinated proteins, potentially increasing the levels of proteins that regulate TTC15. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase 3 (GSK-3), affecting Wnt signaling and possibly the stability or localization of TTC15. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a kinase involved in cell growth and proliferation, which can indirectly affect protein levels including TTC15. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which can modulate the cell's response to stress and potentially affect proteins that interact with TTC15. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, affecting the PI3K/Akt pathway, which can regulate protein synthesis and degradation, potentially influencing TTC15. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII), which can affect cellular processes that potentially regulate TTC15. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, affecting the MAPK/ERK pathway and possibly altering the expression or function of TTC15. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Induces autophagy by inhibiting ubiquitin-specific peptidase 10 (USP10) and USP13, which can affect the degradation pathways of proteins including TTC15. | ||||||